Matches in SemOpenAlex for { <https://semopenalex.org/work/W4313646962> ?p ?o ?g. }
- W4313646962 endingPage "551" @default.
- W4313646962 startingPage "551" @default.
- W4313646962 abstract "Brain tumor glioblastoma is one of the worst types of cancer. The blood-brain barrier prevents drugs from reaching brain cells and shields glioblastoma from treatment. The creation of nanocarriers to improve drug delivery and internalization effectiveness may be the solution to this issue. In this paper, we report on a new nanocarrier that was developed to deliver the anticancer drug doxorubicin to glioblastoma cells. The nanocarrier was obtained by nanoemulsion polymerization of diallyl disulfide with 1-allylthymine. Diallyl disulfide is a redox-sensitive molecule involved in redox cell activities, and thymine is a uracil derivative and one of the well-known bioactive compounds that can enhance the pharmacological activity of doxorubicin. Doxorubicin was successfully introduced into the nanocarrier with a load capacity of about 4.6%. Biological studies showed that the doxorubicin nanocarrier composition is far more cytotoxic to glioblastoma cells (T98G) than it is to cancer cells (M-HeLa) and healthy cells (Chang liver). The nanocarrier improves the penetration of doxorubicin into T98G cells and accelerates the cells' demise, as is evident from flow cytometry and fluorescence microscopy data. The obtained nanocarrier, in our opinion, is a promising candidate for further research in glioblastoma therapy." @default.
- W4313646962 created "2023-01-07" @default.
- W4313646962 creator A5000008708 @default.
- W4313646962 creator A5028535207 @default.
- W4313646962 creator A5036370928 @default.
- W4313646962 creator A5040671086 @default.
- W4313646962 creator A5042493563 @default.
- W4313646962 creator A5057442401 @default.
- W4313646962 creator A5063448578 @default.
- W4313646962 creator A5068570919 @default.
- W4313646962 creator A5071517532 @default.
- W4313646962 creator A5073144933 @default.
- W4313646962 creator A5075685149 @default.
- W4313646962 date "2023-01-05" @default.
- W4313646962 modified "2023-09-26" @default.
- W4313646962 title "Thymine-Modified Nanocarrier for Doxorubicin Delivery in Glioblastoma Cells" @default.
- W4313646962 cites W1470598344 @default.
- W4313646962 cites W1489719702 @default.
- W4313646962 cites W1979524509 @default.
- W4313646962 cites W1980922129 @default.
- W4313646962 cites W1999088373 @default.
- W4313646962 cites W1999620450 @default.
- W4313646962 cites W2005543839 @default.
- W4313646962 cites W2016082816 @default.
- W4313646962 cites W2016956375 @default.
- W4313646962 cites W2021635812 @default.
- W4313646962 cites W2029753193 @default.
- W4313646962 cites W2048265622 @default.
- W4313646962 cites W2052321606 @default.
- W4313646962 cites W2064769568 @default.
- W4313646962 cites W2081121853 @default.
- W4313646962 cites W2084493489 @default.
- W4313646962 cites W2117538553 @default.
- W4313646962 cites W2151467737 @default.
- W4313646962 cites W2154847703 @default.
- W4313646962 cites W2273495465 @default.
- W4313646962 cites W2276073028 @default.
- W4313646962 cites W2296382420 @default.
- W4313646962 cites W2346880338 @default.
- W4313646962 cites W2526011086 @default.
- W4313646962 cites W2554296198 @default.
- W4313646962 cites W2584466409 @default.
- W4313646962 cites W2594448454 @default.
- W4313646962 cites W2599346753 @default.
- W4313646962 cites W2804179781 @default.
- W4313646962 cites W2950672202 @default.
- W4313646962 cites W2962039763 @default.
- W4313646962 cites W2971380049 @default.
- W4313646962 cites W2976551503 @default.
- W4313646962 cites W2981227744 @default.
- W4313646962 cites W2983762161 @default.
- W4313646962 cites W2997516063 @default.
- W4313646962 cites W3024787030 @default.
- W4313646962 cites W3083429764 @default.
- W4313646962 cites W3118061788 @default.
- W4313646962 cites W3118159721 @default.
- W4313646962 cites W3120170115 @default.
- W4313646962 cites W3137728161 @default.
- W4313646962 cites W3214021710 @default.
- W4313646962 cites W4206262557 @default.
- W4313646962 cites W4229760500 @default.
- W4313646962 cites W4244072237 @default.
- W4313646962 cites W651409287 @default.
- W4313646962 doi "https://doi.org/10.3390/molecules28020551" @default.
- W4313646962 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36677608" @default.
- W4313646962 hasPublicationYear "2023" @default.
- W4313646962 type Work @default.
- W4313646962 citedByCount "1" @default.
- W4313646962 countsByYear W43136469622023 @default.
- W4313646962 crossrefType "journal-article" @default.
- W4313646962 hasAuthorship W4313646962A5000008708 @default.
- W4313646962 hasAuthorship W4313646962A5028535207 @default.
- W4313646962 hasAuthorship W4313646962A5036370928 @default.
- W4313646962 hasAuthorship W4313646962A5040671086 @default.
- W4313646962 hasAuthorship W4313646962A5042493563 @default.
- W4313646962 hasAuthorship W4313646962A5057442401 @default.
- W4313646962 hasAuthorship W4313646962A5063448578 @default.
- W4313646962 hasAuthorship W4313646962A5068570919 @default.
- W4313646962 hasAuthorship W4313646962A5071517532 @default.
- W4313646962 hasAuthorship W4313646962A5073144933 @default.
- W4313646962 hasAuthorship W4313646962A5075685149 @default.
- W4313646962 hasBestOaLocation W43136469621 @default.
- W4313646962 hasConcept C121608353 @default.
- W4313646962 hasConcept C126322002 @default.
- W4313646962 hasConcept C139770010 @default.
- W4313646962 hasConcept C141071460 @default.
- W4313646962 hasConcept C1491633281 @default.
- W4313646962 hasConcept C178790620 @default.
- W4313646962 hasConcept C18150654 @default.
- W4313646962 hasConcept C185592680 @default.
- W4313646962 hasConcept C2776694085 @default.
- W4313646962 hasConcept C2777366897 @default.
- W4313646962 hasConcept C2779820397 @default.
- W4313646962 hasConcept C2781303535 @default.
- W4313646962 hasConcept C502942594 @default.
- W4313646962 hasConcept C55493867 @default.
- W4313646962 hasConcept C71924100 @default.
- W4313646962 hasConcept C96232424 @default.